Sky Century Investment (SKYI) Total Current Liabilities (2013 - 2026)
Sky Century Investment (SKYI) posted quarterly Total Current Liabilities of $356253.0 for Q2 2026, down 4.83% year-over-year from $374339.0 in Q2 2025, and down 14.48% quarter-over-quarter from $416593.0 in Q1 2026.
Sky Century Investment (SKYI) Total Current Liabilities (2013 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Total Current Liabilities for 5 consecutive years, with $356253.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Current Liabilities fell 4.83% year-over-year to $356253.0; the TTM figure through May 2026 stood at $356253.0 (down 4.83% YoY), while the FY2025 annual figure was $397449.0, up 35.67% from the prior year.
- Total Current Liabilities declined to $356253.0 in Q2 2026 per SKYI's latest filing, from $416593.0 in the prior quarter.
- Across five years, Total Current Liabilities topped out at $427443.0 in Q4 2025 and bottomed at $292960.0 in Q3 2024.
- Historically, Total Current Liabilities has averaged $366535.7 across 3 years, with a median of $374339.0 in 2025.
- On a YoY basis, Total Current Liabilities climbed as much as 38.54% in 2026 and fell as far as 4.83% in 2026.
- Sky Century Investment's Total Current Liabilities stood at $292960.0 in 2024, then surged by 45.9% to $427443.0 in 2025, then decreased by 16.65% to $356253.0 in 2026.
- Business Quant data shows SKYI's Total Current Liabilities at $356253.0 in Q2 2026, $416593.0 in Q1 2026, and $427443.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | 356,253.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 356,253.00 |
| Feb 28, 2026 | 416,593.00 |
| Nov 30, 2025 | 427,443.00 |
| Aug 31, 2025 | 397,449.00 |
| May 31, 2025 | 374,339.00 |
| Feb 28, 2025 | 300,713.00 |
| Aug 31, 2024 | 292,960.00 |
| Aug 31, 2014 | 40,710.00 |
| May 31, 2014 | 32,280.00 |
| Feb 28, 2014 | 26,700.00 |
| Nov 30, 2013 | 27,000.00 |
| Aug 31, 2013 | 22,200.00 |
| May 31, 2013 | 14,000.00 |